Pharma Regulations for Generic Drug Products in India and US: Case Studies and Future Prospectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharma Regulations for Generic Drug Products in India and US: Case Studies and Future Prospectives

Published:2014 Issue:02 Volume:03 Page:
ISSN:2167-7689
Container-title:Pharmaceutical Regulatory Affairs: Open Access
language:
Short-container-title:Pharmaceut Reg Affairs

Author:

Swain Suryakanta

Publisher

OMICS Publishing Group

Subject

General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on “Regulatory Approval Process of INDA, NDA and Anda in India and Foreign Countries (Us, Europe, China, Australia, Canada)”;International Journal of Innovative Science and Research Technology (IJISRT);2024-03-15

2. The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies;Pharmacology Research & Perspectives;2021-10

3. COMPARATIVE PHARMACEUTICAL EVALUATION OF VARIABLE RETAIL PRICED MEDICINES CONTAINING BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASS-II OR CLASS-IV DRUGS;INDIAN DRUGS;2021-07-12

4. Generic drugs, a need to the public: USA and India – Government plans to reduce the price of abbreviated new drug application and list of generic drugs approved in year 2018;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2019-07-04

5. Generic drugs – The Indian scenario;Journal of Postgraduate Medicine;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP